Why the study?
Does rosiglitazone improve glycemic control in patients with type 2 diabetes mellitus compared to metformin when added to gliclazide?
Cohort (n=25)
No
Does rosiglitazone improve glycemic control in patients with type 2 diabetes mellitus compared to metformin when added to gliclazide?
Answers are grounded in this paper and cite their sources.
Rosiglitazone combined with gliclazide effectively improves glycemic control in patients with type 2 diabetes mellitus.
Diabetes mellitus with one`s chronical complications is the cause of the large percent morbidites and mortality, among the population. With regard to a lot of people who have diabetes mellitus tip 2 (WHO-over 170.000.000 peoples), adequate therapy is very important. By this stady, we wont to show positive consequence new therapy for medication diabetes mellitus typ 2, chiefly application tiazolidinedion in therapy. Handlend 25 patientis with diabetes mellitus typ 2 during 3-mounth observed. Patients were divide in II groups forms on basic of the kind therapy. At the end of 3-mounth, derived results (decrease HbA1c from 7.9%±1.24% to 6.99±0.89%; data value fasting glycemia from 8.99mmol/l±2.08 mmol/l to 7.45±1.35 mmol/l, and value glycemia after meal 10.36 mmol/l±2.18 mmol/l to 8.18 mmol/l±1.31 mmol/l) indicate validity the introduction tiazolidinedion in therapy diabetes mellitus type 2.
No takes yet. Share an insight, caveat, or question.
Pajović et al. (2007) conducted a cohort in Type 2 Diabetes Mellitus (n=25). Rosiglitazone vs. Metformin was evaluated on HbA1c at 3 months (p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: